Please upgrade your browser.
TIVO-1 was the first registrational study in 1st-line RCC to compare an investigational agent against an approved VEGF therapy.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study presented at the 28th Annual EAU Congress currently on-going in Milan.
In her book, Two Weeks of Life: A Memoir of Love, Death, and Politics,Eleanor Clift detailed her experiences after her husband, Tom, was diagnosed with kidney cancer, fully five years before he died.
Small kidney tumours have an agressive potential and should be treated, according to the results of a large multicentre study presented at the 28th Annual EAU Congress in Milan.
“By working with others who specialize in helping people whose lives have been touched by renal cancers, we’ve made remarkable strides in the development of new medicines, along with advancements in surgical interventions, and helping patient families with the psycho-social aspects of dealing with the disease.”
The Cost of Hope: A Candid Roundtable Discussion. ABC News veteran and anchor, Sam Donaldson, moderated the opening session, as he has for the past seven years, following a keynote address from Amanda Bennett, Pulitzer Prize-winning journalist, Executive Editor, Bloomberg News, and author of The Cost of Hope: A Memoir, who spoke candidly about her late husband, Terence Foley, and his battle with kidney cancer.
Although more than 100 soldiers have filed claims for health issues they believe stem from their exposure to Agent Orange while serving in Gagetown, all have been unsuccessful.
Scientists investigate potential markers for a response to sunitinib in patients with metastatic RCC
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
Data detailed on Kidney Disease have been presented. According to news reporting from Taipei, Taiwan, by NewsRx journalists, research stated, "Spontaneous perinephric hemorrhage is a clinically rare life-threatening condition, also known as Wunderlich syndrome. Presentations can be variable, but patients typically display symptoms and signs including flank or abdominal pain, abdominal mass, and hypovolemia."
The conference will be open to all, but is primarily for kidney cancer patients and their families. The conference will be sponsored by the Kidney Cancer Association and chaired by Dr. Christopher G. Wood, Professor and Deputy Chairman, Department of Urology.
|Powered by NeonCRM|